If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Trading Update

19 Jun 2020 12:15

RNS Number : 5329Q
Chamberlin PLC
19 June 2020
 

19 June 2020

Chamberlin plc

("Chamberlin" or the "Company")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to provide a trading update following the announcement on 27 March 2020. 

 

The Company announces that the Walsall foundry reopened for production on 4 May 2020 following a three week closure. The machine shop, which also closed in April, has also reopened for production. While production levels at the Walsall factory are broadly in line with activity seen immediately prior to the impact from Covid-19, output levels at the Machine Shop are running at approximately 30% of that achieved before the COVID-19 measures.

 

Russell Ductile, the Company's Scunthorpe foundry operation, has remained open throughout and continues to operate at full production levels in response to customer demand. 

 

Petrel, Chamberlin's specialist lighting business has also remained open. However, due to suspension of a number of government and defence contracts, Petrel is operating at around 60% of normal sales volumes.

 

The health and safety of Chamberlin's employees has been, and remains, paramount. All operations are performed in line with relevant government guidelines and industry best practice specific to COVID-19 precautions. To date there have been no reported instances of any Chamberlin employee contracting COVID-19.

 

Chamberlin has taken advantage of the UK Government's measures to support business, including the furloughing of staff during the closure of the Walsall sites. The majority of employees are working normally with approximately 18% of the Company's workforce still furloughed.

 

Despite current levels of activity in the Walsall foundry being relatively high, the outlook for a number of the key markets, particularly across the automotive sector, remain uncertain. As a result, Chamberlin has taken steps to reduce costs in line with the expected reduction in demand.

 

Recognising the ongoing uncertainty across global markets, the Board continues to believe that it is too early to make any reasonable estimate of the financial impact on the Group during the current year and beyond.

 

The Company anticipates that the preliminary results for the year to 31 March 2020 will be announced in August 2020.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

 

T: 01922 707100

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

 

T: 020 7397 8900

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUWUQUPUGGB
Date   Source Headline
9th Jun 20112:46 pmRNSHolding(s) in Company
24th May 20117:00 amRNSFinal Results
14th Apr 20117:00 amRNSTrading Update
13th Apr 20115:50 pmRNSTrading Update
12th Apr 20113:51 pmRNSHolding(s) in Company
4th Feb 20117:00 amRNSAcquisition
15th Dec 20102:06 pmRNSHolding(s) in Company
24th Nov 20107:00 amRNSHalf Year Results
26th Oct 20107:00 amRNSMajor Contract Win
26th Oct 20107:00 amRNSMajor Contract Win
24th Sep 20107:00 amRNSPre close Trading Update
13th Sep 20101:30 pmRNSDirector/PDMR Shareholding
29th Jul 20103:24 pmRNSResult of AGM
29th Jul 20107:00 amRNSAGM Statement
13th Jul 20107:00 amRNSDirector/PDMR Shareholding
9th Jul 20107:00 amRNSDirector's Share Dealing
28th Jun 20107:00 amRNSDirector Share Dealing
16th Jun 201010:58 amRNSRe: Applicable Employee
14th Jun 20103:28 pmRNSDirector/PDMR Shareholding
10th Jun 20107:00 amRNSFinal Results
18th May 201012:22 pmRNSBoard Change
15th Mar 201011:41 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSDirector/PDMR Shareholding
27th Nov 20097:00 amRNSHalf Yearly Report
23rd Oct 20097:00 amRNSTrading Update
23rd Jul 20092:37 pmRNSAGM Statement
30th Jun 20095:28 pmRNSPosting of Annual Report and Accounts
9th Jun 20093:08 pmRNSHolding(s) in Company
4th Jun 20097:00 amRNSFinal Results
16th Feb 20097:00 amRNSTrading Update
5th Jan 20097:00 amRNSChange of Adviser
19th Dec 20083:24 pmRNSDirectors Dealings
27th Nov 20087:00 amRNSInterim Results
18th Nov 20087:00 amRNSTrading Update
11th Nov 20087:00 amRNSChange of Nominated Adviser
8th Oct 200810:02 amRNSChange of Adviser Name
28th Jul 20083:17 pmRNSResult of AGM
28th Jul 20082:00 pmRNSAGM Statement
2nd Jul 20084:26 pmRNSDirectors' Dealings
1st Jul 20082:44 pmRNSFinal outcome of nuisance cla
6th Jun 200810:24 amRNSDividend Declaration
5th Jun 20087:00 amRNSFinal Results
25th Feb 20084:33 pmRNSDirector's Dealings
20th Dec 200711:28 amRNSDirector/PDMR Shareholding
27th Nov 200712:43 pmRNSDirector/PDMR Shareholding
27th Nov 20077:00 amRNSInterim Results
17th Aug 20078:25 amRNSAIM Rule 26
6th Aug 20079:47 amRNSChange of Name
31st Jul 20077:00 amRNSTotal Voting Rights
27th Jul 20073:46 pmRNSResult of AGM and Name Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.